Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TCRX compared with PASG: revenue, margins and what each company keeps, and the suppliers and customers both name
TCRX
TScan Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PASG
Passage BIO, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TCRX
TScan Therapeutics, Inc.
vs
PASG
Passage BIO, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TCRX, solid
PASG, dashed
TCRX
TScan Therapeutics, Inc.
Change
0.18
▼
−7.44%
· post 0.18
Mkt cap
$11.8M
Revenue
$1M
Q2 FY26
Revenue
$10M
FY25
PASG
Passage BIO, Inc.
Change
3.44
▼
−2.27%
· post 3.44
Closed
Oct 30 '26
Mkt cap
$11.1M
Revenue
$99,000
Q3 FY24
Revenue
—
vs
Compare
Closed
Oct 30 '26
TCRX
TScan Therapeutics, Inc.
vs
PASG
Passage BIO, Inc.
0.18
▼
−7.44%
post 0.18
Price
3.44
▼
−2.27%
post 3.44
$11.8M
Mkt cap
$11.1M
Q2 FY26
$1M
Revenue
$99,000
Q3 FY24
FY25
$10M
Revenue
—
Change
Change
TCRX
0.18
▼
−7.44%
vs
PASG
3.44
▼
−2.27%
Closed
Oct 30 '26